Vertex Pharmaceuticals Incorporated VRTX stock has declined 4.8% over the past month. This reflects concerns over the ...

Vertex Inc. (NASDAQ:VERX) ("Vertex” or the "Company”), a leading provider of enterprise compliance technology for global commerce and an Oracle partner, today announced Vertex O Series Tax Engine and ...

Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

Hughes to lead hyperscale data center operations, business development, and training across Vertex’s fastest-growing ...

Vertex Pharmaceuticals Inc. shares rose after the biotech company said its drug to treat a kidney disorder met its goal in a late-stage trial, providing a boost to its strategy of moving beyond cystic ...

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

Dr. Brian O'Sullivan, a compassionate pediatrician, fought for affordable cystic fibrosis treatment. He left a lasting legacy in medicine and community.

Vertex Pharmaceuticals (NASDAQ:VRTX) shares rose 6% to $488.52 in premarket trading Thursday after the company reported successful results from a late-stage trial ...

The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida. Designed as an ...

Vertex Pharmaceuticals Inc. VRTX shares are up during Tuesday’s premarket session following positive interim results from one of its Phase 3 trials. The stock’s rise comes as the company is reportedly ...

Vertex Pharmaceuticals Incorporated ( VRTX) Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:30 AM EDT ...

Vertex Pharmaceuticals Incorporated ( VRTX) Leerink Global Healthcare Conference 2026 March 10, 2026 10:00 AM EDT Duncan J. McKechnie - Chief Commercial Officer, Head of North America Commercial & ...